Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| Cencora, Inc.COR · Entity 2994 | Director · Executive Chairman | September 16, 2025 | September 18, 2025 |
| Elevance Health, Inc.ELV · Entity 2934 | Director | May 13, 2026 | May 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 42,003 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 42,003 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Cencora, Inc.
Report date September 16, 2025 · Filed September 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 305,912.665 |
Ending reported balance
After 2025-09-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-16 · Exercise / conversion · Acquired 29,350 · Balance 337,262.665 Row 2 · 2025-09-16 · Sale · Disposed 31,350 · Balance 305,912.665 F1: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24. F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.09 · Expires 2026-11-13 | Direct | 58,699 |
Reported balance
After 2025-09-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-09-16 · Exercise / conversion · Disposed 29,350 · Balance 58,699 F3: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 11/25/24.
F2: The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple tranches ranging from $287.372 to $292.625 inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in the footnote.
F3: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.
Elevance Health, Inc.
Report date May 13, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,202 |
Reported balance
After 2026-05-13 transaction · row 1
1 source rowRow 1 · 2026-05-13 · Grant · Acquired 563 · Balance 4,202 F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 2, 2017 20:03 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-17-020304 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| May 01, 2017 Filed May 2, 2017 20:16 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-17-016339 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| May 01, 2017 Filed May 2, 2017 20:16 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $81.98 | $1,229,700.00 |
DisclosureSEC source: 0001127602-17-016339 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,876 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| May 01, 2017 Filed May 2, 2017 20:16 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-17-016339 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-17-013864 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:06 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $88.35 | $1,325,250.00 |
DisclosureSEC source: 0001127602-17-013864 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,876 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 20:06 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-17-013864 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b-5 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:40 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-17-010200 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016 F2 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:40 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-17-010200 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:40 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $92.10 | $1,381,500.00 |
DisclosureSEC source: 0001127602-17-010200 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4 was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016 Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 21:31 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-17-003561 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4, and in the Form 4's filed by the Issuer with the Securities and Exchange Commission on October 18, 2016, November 2, 2016, December 2, 2016 and January 4, 2017 was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 21:31 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $87.15 | $1,307,250.00 |
DisclosureSEC source: 0001127602-17-003561 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,876 F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4, and in the Form 4's filed by the Issuer with the Securities and Exchange Commission on October 18, 2016, November 2, 2016, December 2, 2016 and January 4, 2017 was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 21:31 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-17-003561 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The exercise of stock options and the sale of common stock reflected in this Form 4, and in the Form 4's filed by the Issuer with the Securities and Exchange Commission on October 18, 2016, November 2, 2016, December 2, 2016 and January 4, 2017 was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:05 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-17-000584 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:05 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-17-000584 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:05 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $80.39 | $1,205,850.00 |
DisclosureSEC source: 0001127602-17-000584 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,876 F1 · kind: The exercise of stock options and the sale of common stock reflected in this Form 4, and in the Form 4's filed by the Issuer with the Securities and Exchange Commission on October 18, 2016, November 2, 2016 and December 2, 2016, was pursuant to a Rule 10b5-1 trading plan previously disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 19, 2016. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:27 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-16-068985 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:27 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-16-068985 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 21:27 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $77.94 | $1,169,100.00 |
DisclosureSEC source: 0001127602-16-068985 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,876 Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:47 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 9,018 | $78.92 | $711,700.56 |
DisclosureSEC source: 0001127602-16-067018 · form4.xml · nonDerivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,181 Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:47 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 27,053 | $80.78 | $2,185,341.34 |
DisclosureSEC source: 0001127602-16-067018 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,199 Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:47 UTC | Cencora, Inc. ABC · Entity 2994 | GrantCommon Stock | 58,695 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-067018 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,876 F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 22:47 UTC | Cencora, Inc. ABC · Entity 2994 | GrantRestricted Stock Units · Derivative | 18,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-067018 · form4.xml · derivative · entry 5 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,516 Underlying: Common Stock · 18,516 shares Expires 2023-11-09 F3 · derivative.exercise_price: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant for no consideration. F3 · derivative.exercise_date: Annual grant of restricted stock units that vests 100% on the third anniversary of the date of grant for no consideration. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 22:47 UTC | Cencora, Inc. ABC · Entity 2994 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 206,642 | $0.00 Strike: $75.61 | $0.00 |
DisclosureSEC source: 0001127602-16-067018 · form4.xml · derivative · entry 4 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,642 Underlying: Common Stock · 206,642 shares Expires 2023-11-09 F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20 Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 22:57 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-16-065935 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 22:57 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $69.85 | $1,047,750.00 |
DisclosureSEC source: 0001127602-16-065935 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,252 Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 22:57 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-16-065935 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2016 Filed Oct 18, 2016 20:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $36.37 | $0.00 |
DisclosureSEC source: 0001127602-16-064917 · form4.xml · derivative · entry 3 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 15,000 shares Expires 2018-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable in four equal annual installments on 02/16/12, 02/16/13, 02/16/14 and 02/16/15 Read SEC document |
| October 17, 2016 Filed Oct 18, 2016 20:09 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 15,000 | $79.59 | $1,193,850.00 |
DisclosureSEC source: 0001127602-16-064917 · form4.xml · nonDerivative · entry 2 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,252 Read SEC document |
| October 17, 2016 Filed Oct 18, 2016 20:09 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 15,000 | $36.37 | $545,550.00 |
DisclosureSEC source: 0001127602-16-064917 · form4.xml · nonDerivative · entry 1 COLLIS STEVEN H · CIK 0001191508 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,252 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.